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Protocol
AbstrACt
Objectives Congenital hemiplegia is the most common form 
of cerebral palsy (CP). Children with unilateral CP show signs 
of upper limb asymmetry by 8 months corrected age (ca) but 
are frequently not referred to therapy until after 12 months ca. 
This study compares the efficacy of infant-friendly modified 
constraint-induced movement therapy (Baby mCIMT) to infant 
friendly bimanual therapy (Baby BIM) on upper limb, cognitive 
and neuroplasticity outcomes in a multisite randomised 
comparison trial.
Methods and analysis 150 infants (75 in each group), 
aged between 3 and 6 months ca, with asymmetric brain 
injury and clinical signs of upper extremity asymmetry will 
be recruited. Children will be randomised centrally to receive 
equal doses of either Baby mCIMT or Baby BIM. Baby mCIMT 
comprises restraint of the unimpaired hand using a simple 
restraint (eg, glove, sock), combined with intensive parent 
implemented practice focusing on active use of the impaired 
hand in a play-based context. In contrast, Baby BIM promotes 
active play requiring both hands in a play-based context. 
Both interventions will be delivered by parents at home with 
monthly home visits and interim telecommunication support 
by study therapists. Assessments will be conducted at study 
entry; at 6, 12 months ca immediately postintervention 
(primary outcome) and 24 months ca (retention). The primary 
outcome will be the Mini-Assisting Hand Assessment. 
Secondary outcomes include the Bayley Scale for Infant and 
Toddler Development (cognitive and motor domains) and 
the Hand Assessment of Infants. A subset of children will 
undertake MRI scans at 24 months ca to evaluate brain lesion 
severity and brain (re)organisation after intervention.
Ethics and dissemination Full ethical approvals for this 
study have been obtained from the relevant sites. The findings 
will be disseminated in peer-reviewed publications.
trial registration number Australian and New Zealand 
Clinical Trials Registry: ACTRN12615000180516, Pre results.
IntrOduCtIOn
Congenital hemiplegia occurs in over 
1 million children under 21 years of age in 
the industrialised world.1 Congenital hemi-
plegia, frequently termed unilateral cerebral 
palsy (UCP), is characterised by a unilateral 
or asymmetric brain injury occurring around 
the time of birth, impacting development of 
hand skills and motor abilities on one side. 
Cerebral palsy is the fifth most costly health 
condition.2 Therefore, early interventions 
that mitigate the brain injury and improve 
early hand function and later vocational and 
life outcomes are urgently needed. Children 
with congenital unilateral or asymmetric brain 
lesions frequently develop hemiplegia with 
major limitations in the use of their impaired 
hand, which results in poor bimanual coor-
dination and impacts on the performance of 
daily activities in home, school and commu-
nity life.
Currently, two very different intensive 
therapy approaches are used each with good 
evidence of improving outcomes for school-
aged children with CP.3 Traditional upper 
limb therapy adopts a bimanual approach 
(BIM) which aims to improve the use of the 
impaired hand as an assisting hand in play 
and functional daily activities.4 More recently, 
modified constraint-induced movement 
therapy (mCIMT) has been introduced, 
strengths and limitations of this study
 ► This study is an adequately powered randomised 
comparison trial of two alternate approaches to 
early intervention for infants at high risk of unilateral 
cerebral palsy.
 ► Primary outcomes are video recorded and assessed 
by a rater masked to group allocation.
 ► At 24 months (corrected age) brain (re)organisation 
will be compared for infants who receive alternate 
treatments.
 ► A controlled trial is not feasible or ethical.
 ► There are limited data published on variations in 
postural upper limb asymmetries and hand function 
for infants under 12 months of age with which to 
compare our data.
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which employs a unimanual approach whereby the unim-
paired hand is constrained in a glove to encourage inten-
sive unimanual training of the hemiplegic arm.5 There 
is speculation that BIM may benefit later bimanual coor-
dination, whereas mCIMT may achieve earlier capability 
in the hemiplegic hand due to specificity of training. 
Other conclusions have been drawn from animal studies 
hypothesising that early mCIMT may have a deleterious 
effect on brain reorganisation (overlateralisation of corti-
cospinal pathways), whereas equal training of both hands 
may reduce such an effect.4 To date, however, neither 
of these approaches have been tested or compared in 
a definitive randomised controlled trial (RCT) in very 
young infants with asymmetric brain lesions. This RCT, 
the Rehabilitation EArly for Congenital Hemiplegia 
(REACH) study, will directly compare an intensive infant 
friendly one-handed approach using mCIMT, called ‘Baby 
mCIMT’, to an equally intensive two-handed (bimanual) 
approach, called ‘Baby BIM,’ in very young infants with 
unilateral or asymmetric brain lesions and clinical signs 
of unilateral CP.
AIMs And hypOthEsEs
broad aim
To conduct a multisite RCT in four states, in Queensland, 
New South Wales, Western Australia and Victoria 
(Australia) with 150 infants (75 in each group) with 
asymmetric brain lesions (congenital or acquired prior 
to 6 months ca) and clinical signs of UCP. This study 
will determine whether Baby mCIMT is more effective 
than Baby BIM in improving infants’ ability to use their 
impaired hand in bimanual play activities (Mini-Assisting 
Hand Assessment (Mini-AHA)) at 12 months corrected 
age (ca). The secondary outcomes will test the differential 
effect of each approach on fine motor (Hand Assessment 
of Infants (HAI)) and Bayley Scale for Infant and Toddler 
Development (Bayley-III; motor and cognitive domains) 
at 12 and 24 months ca. in addition to symmetry of the 
corticospinal pathway development and its relationship 
to bimanual activities at 24 months ca.
Major hypothesis to be tested
H1 Baby mCIMT improves the symmetrical development 
of reach and grasp (unimanual capacity, HAI) to a greater 
extent than Baby BIM leading to better bimanual coordi-
nation (Mini-AHA) at 12 months ca.
secondary hypotheses
H2 Baby mCIMT is more effective than Baby BIM in 
enhancing fine motor and cognitive development at 12 
and 24 months ca (Bayley-III) and better participation in 
play, self-care activities and social functioning (Pediatric 
Evaluation of Disability Inventory Computer Adapted 
Test (PEDI-CAT)).
H3neuroplasticity of the key motor networks, as 
measured by structural connectivity, is enhanced and 
associated with improved bimanual function at 24 months 
ca in infants undertaking Baby mCIMT compared with 
those receiving Baby BIM therapy.
The primary aim of our study is to test the major 
hypotheses in an RCT conducted according to Consoli-
dated Standards of Reporting Trials (CONSORT) guide-
lines6 where we aim to determine if Baby mCIMT confers 
superior and lasting benefits on use of the impaired hand 
in bimanual activities over Baby BIM therapy.
Our secondary aim is to determine if there is a differ-
ential impact of Baby mCIMT and Baby BIM on early 
cognitive and fine motor development (Bayley-III) and 
better participation in play, self-care activities and social 
functioning (PEDI-CAT) in association with early brain 
reorganisation (diffusion MRI (dMRI) at 24 months ca). 
Enhancing our understanding of the neural mechanisms 
underlying early development of upper limb function and 
bimanual coordination according to the type of interven-
tion will provide important evidence as to the mechanisms 
underlying children’s responses to the type of interven-
tion and the impact on early brain development. To 
achieve this, we will use dMRI and structural connectivity 
analyses to evaluate white matter development in motor 
networks controlling movement in infants receiving Baby 
mCIMT or Baby BIM therapy at 24 months.
This clinical trial will be conducted across four states of 
Australia where there is access to populations of infants 
with hemiplegia through respective state-wide rehabilita-
tion services and the Australian Cerebral Palsy Register 
(ACPR).7 Children with hemiplegia usually attend regular 
schools; however, severity of their hemiplegic arm impair-
ment reduces independence in activities of daily living, 
compromises participation in education and leisure and 
can influence their later vocational aspirations. Very early 
rehabilitation with the most effective therapy that leads 
to sustained improvements in function and neurological 
structure could have profound effects on later participa-
tion offering a cost-effective and timely model of care. 
Improving our understanding of the mechanisms of 
response to therapy is essential to providing effective and 
timely treatment to achieve sustained outcomes.
Evidence for mCIMT and bimanual upper limb rehabilitation in 
congenital hemiplegia
Our meta-analysis reported the efficacy of interventions 
on improving upper limb dysfunction for school-aged 
children with hemiplegia.3 There was moderate to strong 
evidence that the original approach to CIMT (with a long 
cast on the unimpaired arm combined with intensive 
shaping) or modified CIMT (using a glove on the unim-
paired hand with activity-based training) was more effec-
tive than usual care to improve the quality and efficiency 
of arm movement. When mCIMT was compared with an 
equal dose of bimanual therapy at school age, there were 
differential effects related to the specificity of training.8 It 
remains unclear, however, whether one approach is supe-
rior in infants as the majority of studies did not include 
children under 1 year of age. Despite the philosophical 
preference for very early intervention to optimise brain 
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neuroplasticity, there is limited research on early upper 
limb rehabilitation for infants less than 12 months ca.9 It 
is important to test the efficacy of these two approaches 
to upper limb therapy in young infants where there is 
greater potential to harness neuroplasticity.
Cortical reorganisation after an early brain lesion: a critical window
For infants with early brain lesions, there are important 
phases of sensorimotor reorganisation in the first year10 
with two main types of brain reorganisation.11 Ipsilesional 
reorganisation (ie, reorganisation within spared cortical 
tissue of the damaged hemisphere) allows the damaged 
motor cortex to become reconnected to the spinal cord, 
as observed in adults following stroke.12 Contralesional 
reorganisation (ie, reorganisation in the undamaged 
cortex) occurs when existing ipsilateral motor projections 
remain intact instead of becoming retracted within the 
first months of life. This alternate type of reorganisation 
occurs in very early brain lesions11 and can lead to severe 
motor impairment due to dissociation of the primary 
sensory and motor pathways13 14 (figure 1. It is proposed 
that the first 3–6 months following an asymmetric brain 
lesion provides a critical opportunity for interventions 
to influence lateralisation of the corticospinal (CS) 
Figure 1 CONSORT flowchart. ACPR, Australian Cerebral Palsy Register; BIM, bimanual approach; CONSORT, Consolidated 
Standards of Reporting Trials; DASS, Depression Anxiety Stress Scale; mCIMT, modified constraint-induced movement therapy; 
EA-SR, Emotional Availability Self-Report Scale; PRIME-G, Pediatric Rehabilitation Intervention Measure of Engagement 
General Research Version. 
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pathways.15 When sparing of the CS tract is present, 
early intervention may shape cortical reorganisation and 
improve outcomes.
To date, there is limited human evidence to deter-
mine which interventions lead to ipsilesional rather than 
contralesional reorganisation. Animal studies provide 
strong evidence that the type of training (mCIMT or 
BIM) may differentially impact early brain (re)organisa-
tion in infants with asymmetric brain lesions.16 A review of 
feline model studies supports the initiation of prehensile 
training in infants before 6 months.17 This review indi-
cated a strong correlation between activation of the CS 
tracts and strength of synaptic connections with spinal 
motor circuits supporting the hypothesis that early brain 
damage might initiate a vicious cycle where damaged CS 
tracts are competitively disadvantaged from maintaining 
spinal synapses, resulting in secondary reductions in 
these connections.17 More recently, the same research 
group examined whether targeted activation of spared 
CS tracts led to functional improvement by exploring the 
effects of early intervention in cats with M1 inactivation.16 
Three groups were studied: (1) early restraint alone with 
no training of the impaired limb which equals infant 
age forced use; (2) early restraint plus training which 
equals infant CIMT and (3) late restraint plus training, 
which equals restraint and training at feline adolescence. 
Outcomes measured were: (1) CS tract connections, (2) 
M1 motor maps and (3) motor performance. Restraint 
alone was able to restore CS tract connectivity yet failed to 
impact M1 motor maps or motor function. Late training 
impacted both CS tract connectivity and motor maps but 
failed to induce significant functional recovery. The only 
intervention resulting in major improvements in all three 
measures of outcome was early restraint combined with 
training.16 These animal data support infant mCIMT for 
rehabilitation of children with asymmetric brain lesions.
Evidence from advanced brain imaging in children with congenital 
hemiplegia
The importance of a multilevel network in the reorgani-
sation of the CS system has been suggested by our work 
in children with congenital hemiplegia.18 The devel-
oping connectivity and symmetry of the thalamocortical 
pathways connecting M1 with the motor thalamus is as 
important as the symmetry of the CS tracts for unimanual 
capacity and bimanual coordination.18 19 High Angular 
Diffusion Imaging was performed to evaluate symmetry 
in the CS (motor) and thalamocortical (sensorimotor) 
tracts. Surprisingly, microstructural measures of the senso-
rimotor thalamic tracts were more significantly correlated 
with paretic hand function than those of the CS tracts. 
These data suggest functional outcome is not only related 
to the integrity of the CS tract but also requires feedback 
from sensory systems to shape the motor cortex and 
underlying pathways.15 18
To date, upper limb rehabilitation studies have focused 
on interventions to promote activation of the motor 
tracts alone with little regard to a balance of input to and 
from the sensory tracts.3 18 These data on rehabilitation 
and (re)organisation in UCP support a two-handed or 
bimanual approach to early rehabilitation. As evidence 
supports alternative approaches, mCIMT from animal 
studies and BIM from advanced MRI, in addition to 
the marked lack of evidence for an effective treatment 
for infants at risk of hemiplegia,20 there is an urgent 
need for further randomised clinical trials. The study 
proposes a direct comparison between the two alternative 
approaches (Baby mCIMT and Baby BIM) in very young 
infants at risk of hemiplegia.
MEthOds
Full ethical approvals for this study have been obtained 
from the relevant sites in Queensland, Perth, Melbourne 
and New South Wales. Written and informed consent 
will be obtained from all parents or guardians of partici-
pants before entering the trial. This trial has been regis-
tered with the Australian New Zealand Clinical Trials 
Registry (ACTRN12615000180516).21 This study protocol 
is reported according to the Standard Protocol Items: 
Recommendations for Intervention Trials statement 
(SPIRIT; 2013).
study design
A single-blinded randomised comparison trial will 
compare Baby mCIMT and Baby BIM in infants with 
congenital or early acquired hemiplegia with unilateral 
or asymmetric brain lesions according to CONSORT 
guidelines (see figure 1).
recruitment
Participants
One hundred and fifty infants aged between 3 and 6 
months ca at study entry with unilateral or asymmetric 
brain lesions (identified on cranial ultrasound or MRI) 
prior to 12 weeks post-term and clinical signs of hemi-
plegia will be recruited. These infants will be identified 
from neonatal follow-up clinics at the following sites 
in four states of Australia: in Queensland at The Lady 
Cilento Children’s Hospital (LCCH), Royal Brisbane and 
Women’s Hospital, Mater Mothers Hospital, Sunshine 
Coast University Hospital and the Gold Coast University 
Hospital; in New South Wales at The Cerebral Palsy Alli-
ance and the Children’s Hospital at Westmead, Sydney; 
in Victoria at The Royal Children’s Hospital and Monash 
Medical Centre Melbourne and in Western Australia 
at The Perth Children’s Hospital and the King Edward 
Memorial Hospital for Women, Perth, in addition to the 
ACPR. It is predicted that 364 infants will be born with 
asymmetric brain injuries over the 2 years of recruitment, 
so that recruitment of 150 infants (41% of eligible) is 
feasible.
Inclusion criteria
Participants will be recruited at ≤6 months ca (+14 days), 
have English spoken in the family and have the following 
by 6 months (+14 days) ca:
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1. Asymmetric brain lesion identified on cranial ultra-
sound or MRI including asymmetric (one-sided or more 
involved on one side) or unilateral brain injury including:
 ► Preterm or term arterial stroke;
 ► Grade III or IV intraventricular haemorrhage;
 ► Asymmetric periventricular leucomalacia;
 ► Asymmetric deep grey matter lesions;
and
2(a): Absent Fidgety Movements on General Move-
ments Assessment (GMs) at 12 weeks ca;
or
2(b): Abnormal Hammersmith Infant Neurological 
Examination (HINE) between 18 to 26 weeks ca; the 
Hammersmith Infant Neurological Evaluation (HINE) is 
a standardised neurological examination of cranial nerve 
function, posture, quality and quantity of movement, tone 
and reflexes and reactions, which has numeric scoring. A 
HINE score at 3 months <57 is 96% predictive of cerebral 
palsy.22–25
and
3. Asymmetry of upper limb reach and/or grasp on 
the HAI (>3 point difference) that is congruent with the 
asymmetry found on the early cranial ultrasound (CUS) 
or brain MRI (ie, opposite to likely side of the lesion).
Exclusion criteria
Infants will be excluded if they have:
1. Epilepsy uncontrolled by medication as this would be 
a confounder;
2. Retinopathy of prematurity > grade two or cortical 
blindness whereby visual tracking on clinical assess-
ment is not possible will be excluded;
3. Ventriculo-peritoneal shunts.
Confirmation of diagnosis/motor distribution
At 12 months ca, the diagnosis of congenital hemiplegia 
or UCP will be confirmed by a paediatrician, rehabilita-
tion physician or neurologist using a structured proforma 
of motor type and distribution. HINE will be performed 
at 12 and 24 months ca.
Brain MRI at 24 months ca will assess asymmetry of 
corticospinal and thalamocortical tracts and unilateral/
bilateral brain lesions using both a semiquantitative 
scale26 and quantitative analysis of microstructure on 
dMRI, which will enable secondary subgroup analysis 
(unilateral/asymmetric bilateral).
Comorbidities
Presence and severity of epilepsy (controlled by medica-
tion), visual fields (hemianopia) and/or hearing deficits 
will be assessed by a medical physician at 12 months ca.
Randomisation process
Children will be randomised centrally at the Queensland 
site to receive either Baby mCIMT or Baby BIM using a 
concealed centralised electronic allocation system deter-
mined by non-study personnel. After baseline assessment 
and informed consent, children will be stratified centrally 
for age at entry (3-4/5-6 months), gender (male/female), 
side of lesion (right/left) then randomised. Allocation 
will be confirmed to the local study therapist from the 
central study coordinator after the participant has been 
enrolled and baseline data have been collected.
Blinding
Structural MRI data will be qualitatively and quantitatively 
analysed at 24 months ca by a child neurologist masked 
to group allocation and previous history. Data for the 
Mini-AHA and Small-kids AHA at 12 and 24 months ca, 
respectively, will be rated from videos by an independent 
accredited rater masked to group allocation. Analyses will 
be performed using coded study allocation.
Study procedure
Study interventions
i. Infant-friendly modified constraint-induced 
movement therapy (Baby mCIMT): comprises 
restriction of use of the unimpaired limb using a 
simple restraint such as a glove, sock or sleeve with a 
bag clip combined with intensive play-based activity 
with the hemiplegic arm (table 1).
Theoretical framework of Baby mCIMT: Baby mCI-
MT27 is a further modification of mCIMT,28 adapted 
to very young babies at high risk of developing unilat-
eral CP. In the present clinical trial, Baby mCIMT has 
been designed in close collaboration with Professor 
Ann-Christian Eliasson who developed Baby CIMT 
and eco-CIMT.9 29 Baby mCIMT aims to improve the 
ability of the ‘impaired’ hand at a very early age, when 
movement skills are developing and when neural plas-
ticity may allow interventions to be more effective.17 
To achieve this, some ‘restraint’ of the non-impaired 
hand is typically needed during the practice time. 
Children are stimulated to use the impaired hand 
through presentation of a carefully selected set of 
age appropriate and engaging toys and play objects. 
Practice will be implemented in infants’ daily environ-
ments by their parents under the guidance of study 
therapists.
Baby mCIMT considers both developmental and abil-
ity constraints as well as perceptual, cognitive and 
environmental influences on the use of the impaired 
arm/hand. Physical assistance will be kept to a min-
imum but may be used judiciously to facilitate Baby 
mCIMT. Toys/tasks will be carefully selected for their 
developmental, therapeutic and engaging properties, 
and the environment may be manipulated to support 
the child with achieving unimanual skill development.
Baby mCIMT is approached from a number of differ-
ent perspectives:
 – For children with UCP, the ability to use their 
involved hand for reaching, grasping and object 
manipulation does not develop at the same rate 
or in the same way as that of their non-involved 
(preferred) hand. The impact of unilateral 
impairment on hand use needs to be considered 
to organise the intervention both from a 
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developmental perspective and also to target the 
correct motor ability level.
 – Children’s interests, motivation, cognitive 
and perceptual capacities, will be important 
considerations when selecting toys/tasks to 
promote use of the impaired hand/arm.
 – Parents will be supported to carry out Baby 
mCIMT at home with monthly home visits by an 
occupational therapist or physiotherapist trained 
in the implementation of the intervention, 
remote contact (Skype/Facetime/WhatsApp 
or telephone) between home visits and written 
material.
ii. Baby BIM: comprises play-based activity designed 
to encourage the use of both the impaired and 
unimpaired upper limbs during bimanual activities.
Theoretical framework of Baby BIM: In contrast to 
Baby mCIMT, Baby BIM uses an approach that en-
courages the two hands to be used together with a 
focus on developing bimanual skills. Bilateral arm 
movements are the predominant pattern of upper ex-
tremity movements in the first year of life,30 as humans 
are essentially bimanual beings. The developmental 
sequence of bimanual skills observed during infancy 
are related to the infant’s postural, sensory, perceptual 
and cognitive development as well as unilateral hand 
skill development.31 It is currently not known whether 
improvements in unilateral hand skill development 
will automatically lead to improvement in bimanual 
performance or whether focussing on developing spe-
cific bimanual skills would be more effective.
Similar to Baby mCIMT, Baby-BIM is designed for very 
young children up to approximately 12 months ca who 
have or who are ‘at risk’ of developing UCP. Baby BIM 
aims to improve the ability of the involved hand at a 
very early age, when movement skills are developing 
and when neural plasticity may allow interventions to 
be more effective.17
Baby BIM considers both developmental and ability 
constraints as well as perceptual, cognitive and envi-
ronmental influences that may impact the use of two 
hands. Physical assistance may be used judiciously to 
encourage motor activity. Toys and tasks are carefully 
selected for their developmental, therapeutic and en-
gaging properties, and the environment may be ma-
nipulated to support the child undertake bimanual 
activity.
Baby BIM is approached from a number of different 
perspectives:
 – An understanding of the bimanual motor actions 
which exist at different ages is required.
 – For children with UCP, the ability to use their 
involved hand for reaching, grasping and object 
manipulation does not develop at the same rate 
or in the same way as that of their uninvolved 
hand. The impact of the unilateral impairment 
on bimanual hand use needs to be considered 
to organise the intervention both from a I
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developmental perspective and also to target the 
correct motor ability level.
 – Children’s interests, motivation, cognitive and 
perceptual capacities, which develop over this 
first year of life, are important considerations 
when selecting toys/tasks to promote bimanual 
skills.
 – Parents are supported to carry out Baby 
BIM at home with monthly home visits by an 
occupational therapist or physiotherapist trained 
in the delivery of the intervention, remote contact 
(Skype or telephone) and written material.
Implementation of Baby mCIMT and Baby BIM
Preparation and planning of intervention sessions will 
be an important part of implementing both the Baby 
mCIMT and Baby BIM programmes. Study therapists 
will be provided with comprehensive Baby mCIMT and 
Baby BIM manuals developed by the REACH investi-
gators to help guide their intervention sessions. The 
manuals will include important background knowledge 
about the typical sequence of upper limb develop-
ment from zero to 12 months. Three ability levels have 
been developed for the Baby mCIMT and Baby BIM 
programmes to guide intervention implementation 
based on ability levels observed when completing the 
HAI.32 These are:
Level 1: Reaching and early grasping
Level 2: Grasping
Level 3: Refinement of grasp and object manipulation
Although these levels are age related in typically devel-
oping infants, the motor, cognitive and developmental 
level of each child with or at risk of UCP needs to be the 
primary consideration in identifying the appropriate 
level at which to target Baby mCIMT or Baby BIM. For 
each of the three ability levels, comprehensive informa-
tion is provided in the intervention manuals to guide 
therapy. This includes: (1) an overview of development 
of unimanual or bimanual ability at this level, (2) an over-
view of perceptual and cognitive influences, (3) princi-
ples of intervention at that level for each model and (4) a 
table providing specific treatment strategies organised by 
person, environmental and task considerations for each 
skill.
Using these levels aims to facilitate selection of 
important actions to practice at the right ability level to 
support the development of unimanual and/or bimanual 
skills.33
Use of assessment information for treatment planning
Information from completing the HAI and clinical obser-
vations of posture and movement will be used to identify 
the level at which unilateral and bimanual play activities 
should be targeted.27
 ► Young babies (3–4 months of age) and babies whose 
HAI result shows they may not have the ability to grasp 
with the involved upper limb will commence at level 1.
 ► Babies whose HAI result shows they have rudimentary 
grasping skills with the involved upper limb will start 
at level 2.
 ► Babies whose HAI result shows that they have good 
grasping skills in the involved upper limb and require 
further skill development will start at level 3.
 ► Over the course of the intervention period, as the 
infant develops new hand skills, they will be progressed 
through the levels of ability to ensure the continued 
‘just right challenge’ and to continue to refine and 
improve the child’s hand and arm ability.
Venue: home programme is optimal for best practice
The most effective partnership-based home programmes 
include five steps: (1) establishing a collaborative part-
nership, where the parent is the expert in knowing 
their child and their home environment; (2) having the 
child and family (not the therapist) set goals about what 
they would like to work on in the home environment; 
(3) establishing the home programme by choosing 
evidence-based interventions that match the child and 
family goals and empowering the parents to devise or 
exchange the activities to match the child’s preferences 
and the unique family routine; (4) providing regular 
support and coaching to the family to identify the 
child’s improvements and adjust the complexity of the 
programme as needed and (5) evaluating the outcomes 
collaborative.34 This study will adopt these evidence-
based principles in the development of the home 
programme.
Intensity of intervention
The REACH trial requires parents to complete play 
sessions to provide a specific dose of intervention per day, 
with the same dose in both Baby mCIMT and Baby BIM 
models of intervention. The proposed optimal dosage 
varies according to age, as follows:
 ► Infants aged 3–6 months ca: 20 min per day, 5 days per 
week;
 ► Infants aged 6–9 months ca: 30 min per day, 5 days per 
week;
 ► Infants aged 9–12 months ca: 40 min per day, 5 days 
per week.
The dosage does not need to be completed in one 
session. Play sessions may be spread over the day. For 
example, a child of 10 months may have four sessions 
of 10 min to achieve 40 min of intervention per day. 
To date, there are no evidence to support the optimal 
dose for intervention according to the child’s age. The 
session times proposed in the REACH trials are shorter 
than those used with older children because: (1) babies’ 
attention spans are short and (2) small doses allow time 
for families to attend to the multiple demands on their 
time and to fit intervention between other needs such as 
feeding, physical care and sleeping. The total overall dose 
will be 70 to 89.2 hours by 12 months ca depending on 
infant’s age at the time of recruitment (between 3 and 
6 months ca).
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Procedures for both interventions
Baby mCIMT and Baby BIM will be implemented by 
parents in the home environment, supported by an 
occupational therapist or physiotherapist trained in 
the delivery of each intervention. Home visits will be 
conducted once per month from the time of recruit-
ment until 12 months ca. At the initial home visit baseline 
assessments will be completed following which infants will 
be randomised to one of the two interventions. A further 
aim of the initial home visit is to understand the family 
environment and determine the learning and support 
needs of the family, provide education about the interven-
tion to which the infant has been allocated and establish 
a home programme. Subsequent home visits will occur 
once per month and are expected to range between 1 
to 1.5 hours duration. During the home visit, therapists 
will collect information since the previous visit or remote 
contact with the family, review the home practice diary 
and home programme, complete a play session in collab-
oration with the family and plan and document the next 
focus areas for intervention. Two weeks after each home 
visit, the therapist will contact the family via Skype or tele-
phone, depending on the preferences of the family. The 
aim of this contact is to support the family in the delivery 
of the home programme, review the infant’s progress and 
update the home programme as required.
Both programmes have: (1) the same dosage, (2) 
varied construct and (3) are delivered by parents in the 
home environment with the support of an occupational 
therapist or physiotherapist. To ensure the same treat-
ment dose is delivered within and between each treat-
ment arm, a range of strategies will be implemented. 
The intervention manuals developed for Baby mCIMT 
and Baby BIM clearly describe the treatment dose and 
scheduling. Computerised scheduling will be established 
in a Research Electronic Data Capture (REDCap) data-
base, which will provide therapists with a prompt for 
intervention contacts. At the completion of each home 
visit and remote contact, the therapist will complete an 
online questionnaire (Qualtrics) which will record any 
deviations from the dose protocol and reasons and the 
amount of contact time provided. The questionnaire will 
further prompt therapists about the scheduling for the 
next contact with the participant. In planning for any 
potential setbacks, more than one therapist at each site 
will be trained to deliver each intervention. In the case 
of a missed home visit or remote contact, therapists will 
reschedule the appointment within a 2-week time frame. 
Each family will complete a home practice diary, which 
will be reviewed by the therapist at each home visit and 
uploaded on a central database (REDCap). The home 
practice diary will record the amount of daily home prac-
tice (in minutes), the activities practised and any ques-
tions for the therapist at the subsequent contact.
Role of the study therapist
Consistent with the principles of shared decision-making,35 
the therapist will work in partnership with the family to 
determine how and when intervention will be under-
taken so as to accommodate daily family routines while 
adhering to intervention protocol. Ensuring that the 
parent feels emotionally supported, the therapist will 
provide the rationale for the specific intervention being 
undertaken. Drawing on the parent’s knowledge of the 
child together they will tailor the activities relevant to 
either Baby mCIMT or Baby BIM. Through informa-
tion exchange, the therapist will situate the solutions for 
how to progress the intervention with the family thereby 
reinforcing a sense of self efficacy in the delivery of the 
intervention.36 Along with adopting a solution-focused 
coaching approach37 during home visits, the therapist will 
remain in regular telecommunications contact to help 
resolve any implementation challenges as these may arise.
Positioning the infant for the therapy programme
During study intervention, the infant should be in as 
upright and stable a position as possible. This allows the 
infant to more easily use goal-directed arm movements 
with their attention focused on the play situation.38 At 
times, in the HAI first ability level, play in semisupine 
nestled in the parent’s lap and facing the parent may 
be used to orient infants towards toys and other play 
objects. The prone position should be avoided as this 
is a difficult position in which to encourage unimanual 
or bimanual skills. A baby chair/high chair is preferable 
for the programme once an infant has head control in 
supported sitting and when the baby only needs to be 
held around the trunk when sitting on a lap. The infant 
should be stable when using an infant seat, and appro-
priate supports may be required to improve stability. The 
child should not be practising sitting balance when the 
focus is on use of upper limbs and hands as the quality 
of postural control is known to influence exploration 
and the quality of object manipulation.39 40 A table at the 
appropriate height and close to the body is also encour-
aged as it is useful for eliciting grasp of toys placed in 
various positions.
Supporting the parent–infant relationship and parent mental health
Both interventions will be conducted in a manner consis-
tent with supporting parental mental health and sensitive, 
responsive parenting. Dr Koa Whittingham, a registered 
clinical and developmental psychologist and investigator 
on this project, is responsible for developing the parental 
mental health and parenting support component of 
the intervention manuals, for training all of the ther-
apists in parental mental health and parenting support 
and for providing ongoing mentorship and advice to 
therapists as needed throughout the trial. The parental 
mental health and parenting support components will 
be developed grounded in three key theoretical frames: 
the emotional availability literature,41 the grief and loss 
literature including chronic sorrow theory42 and Accep-
tance and Commitment.43 Training will focus on enabling 
therapists to better support parental grief and to recog-
nise and support responsive parenting. If parental mental 
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health or the parent–infant relationship is found to be 
a significant concern, either arising directly from ther-
apist–parent contact or from parental scores on the 
Depression Anxiety Stress Scale (DASS) or Emotional 
Availability Self-Report Scale (EA-SR), then appropriate 
referral options will be discussed with the parent.
Delivery and fidelity
The United States National Institute of Health 
Behaviour Change Consortium has recommended a 
model of fidelity comprising five areas for consider-
ation.44 The five areas encompass study design, training 
of intervention providers, treatment delivery, treatment 
receipt and enactment. While this model was developed 
for psychological interventions, it has been adopted in 
rehabilitation focused research.45 46 The model provides 
an overarching framework for addressing fidelity in the 
current study. All therapists implementing Baby mCIMT 
and Baby BIM will participate in standardised training. 
Training will include certification in conduct of the HAI 
(2 days), Mini-AHA if not already certified (3 days) and 
intervention delivery and study procedures (2 days). 
The standardised training for intervention delivery and 
study procedures will be video recorded to be used if new 
study therapists require training over the 4-year study 
period. Standardised training manuals will be provided 
for each study therapist. The standardised training will 
include both didactic and interactive elements encom-
passing the rationale underpinning each intervention, 
engaging and working effectively with families, prin-
ciples of family-centred practice and coaching, infant 
ability levels determined through the HAI, interven-
tion planning, toy selection, implementation of Baby 
mCIMT and Baby BIM including video case vignettes. 
In addition, therapists will be familiarised with the inter-
vention manuals and a series of nine worksheets that 
will be used in the implementation of each intervention 
protocol to further enhance standardisation of interven-
tion delivery. Four of these worksheets are for the study 
therapists to prompt the delivery of essential elements 
of the intervention. These include a mind map to guide 
therapists in provision of necessary information about 
each intervention to the parent, a guide and checklist 
for structuring home visit sessions, a standardised home 
programme template and questionnaire completed by 
the study therapist at the conclusion of each home visit 
to reflect on their performance and engagement with 
the family.
A questionnaire using a five-point Likert scale developed 
for the study will evaluate the therapists’ self-perceived 
knowledge, skills, beliefs and confidence in delivering 
each intervention. This will be administered prior to and 
at the completion of the standardised training, and then 
at 6, 12, 18 and 24 months post to monitor any poten-
tial drift and implement booster sessions if indicated. 
Monthly Skype/web-based meetings among study ther-
apists will occur to provide ongoing mentorship and 
support to implement the interventions. Each study 
therapist will have a chief investigator at their local site to 
provide support, supervision and mentorship.
A provider delivery observational checklist will be 
developed to evaluate treatment adherence, treatment 
differentiation and therapist competence in delivery of 
core intervention components. Essential and proscribed 
elements of each intervention will be defined based on 
the intervention manuals and training resources. Core 
elements will be worded into observable actions and 
behaviours to reflect both adherence to the protocol 
and the quality by which the interventions have been 
delivered (competence items). A coding manual will be 
developed for each item on the checklist. Content validity 
of the checklist will be determined by an expert panel 
comprising REACH study investigators and developers 
of the intervention manuals and standardised training. 
To determine if the items measure what they intend (ie, 
adherence, competence, treatment differentiation), an 
expert panel comprising REACH study investigators will 
review each item in the checklist. Inter-rater and intra-
rater reliability will be established.
Study therapists will videotape all home visit sessions. 
Videotaped sessions will be uploaded centrally 
(Queensland site). The first two home visits for each ther-
apist delivering each intervention will be reviewed inde-
pendently by two study investigators at the Queensland 
site against the Provider Delivery Observational Check-
list. A random sample of videos will then be selected over 
the course of the study so that approximately 10% of each 
therapists’ intervention sessions will be evaluated using the 
Provider Delivery Observational Checklist. A threshold of 
80% compliance to checklist items will be applied and 
deviations in excess of this will result in feedback to the 
study therapist’s local site supervisor. The supervisor and 
study therapist will then review and determine strategies 
to mitigate further deviations from protocol.
A range of strategies will be employed by the study ther-
apists for monitoring and improving the receipt of treat-
ment. Worksheets developed to enhance the parents’ 
delivery of the intervention include a guide to preparing 
for a play session, choice of restraint (for Baby mCIMT 
group only), a mind map (Are you ready to play?) to 
prompt parents around the optimal time and environ-
ment to play with their child and a mind map (How did the 
session go?) to encourage parents to reflect on their play 
session with their child. As part of the structured home 
visit, study therapists will ask the parents to demonstrate 
the intervention activities they have been practising with 
their child and the toys they have selected. Therapists will 
provide feedback on parent performance and highlight 
the child’s progress. As the child progresses in develop-
ment of their hand skills, therapists will provide demon-
stration of the next stage/goals of therapy and discuss 
features of objects/toys that may elicit the behaviours 
that are being targeted. Therapists will employ coaching 
strategies with the families to help them consider toys/
objects they could use in their own environment. Collab-
orative discussions will enable therapists to determine if 
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the parents understand the next therapy goals. Families 
may videotape their child during the session as a prompt 
to assist them in the delivery of the treatment in between 
therapist contacts.
Parents will be independently interviewed when their 
infant at baseline, midway through each infant’s inter-
vention period and at 12 months ca to determine how 
they are reacting to the intervention requirements, the 
extent to which delivery is feasible in their family context 
and their reaction to changes they may have observed in 
their child. This interview will follow parent’s comple-
tion of the Pediatric Rehabilitation Intervention Measure 
of Engagement (General Research Version) (PRIME-
G). The PRIME-G has been developed to gain parent’s 
perspective on their own engagement in their children’s 
therapy.
Intervention content and implementation
Details of the implementation of Baby CIMT and Baby 
BIM are presented according to the
template for intervention description and replication 
(TIDieR) checklist and guide in Table 1.47
Concurrent therapies
Concomitant interventions (eg, PT, OT) provided during 
the study period until 24 months ca will be recorded using 
a logbook. Infants are not expected to receive intramus-
cular botulinum toxin A to the upper limb as it has not 
received regulatory approval for infants with CP less than 
2 years of age in Australia. Rigid casting will be discour-
aged as there is no published evidence of functional bene-
fits for infants with hemiplegia less than 24 months ca. 
Night splinting, if used will be recorded in the logbook.
Outcome classification and exit criteria
Infants recruited to the study will be assessed at specific 
time points including at 6 months ca for cross-sec-
tional analysis of the study population on asymmetry of 
reach/grasp (HAI), at the conclusion of intervention 
at 12 months ca on bimanual coordination (Mini-AHA) 
and general development (Bayley-III). The diagnosis 
of hemiplegia (by motor type and distribution) will 
be confirmed independently by medical personnel 
at 12 months ca using a structured proforma. If there 
is deterioration of development of hand skills of the 
less impaired hand in either intervention group quan-
tified as a difference of <3 points on the unimpaired 
hand compared with the impaired hand, the case will 
be presented to the independent data monitoring and 
safety committee (DMSC) to determine if stopping rules 
have been met.
Adverse events
Any adverse events associated with either intervention will 
be screened at 6, 12 and 24 months using open-ended 
questions asked by non-treating personnel. Families are 
monitored for parent mental health and parent/child 
attachment at baseline, 6 and 12 months ca using DASS48 
and EA-SR.49
Data Management Safety Committee
Three independent researchers will comprise the DMSC. 
They will review all adverse events, subject participant 
retention in each arm of the study and compliance with 
study protocol at 12 monthly intervals.
Baseline assessments at study entry
Measurement of unimanual capacity will be performed 
using the HAI27 32 at study entry, then at 6 months ca to 
describe the study sample.
1. Classification of the Early Brain Injury: The Kidokoro 
Scale50: scoring of structural MRI to classify brain 
injury and growth has been validated for use at term 
equivalent age (TEA) in infants born preterm.50 51 
Qualitative scoring systems of MRI at TEA include 
quantitative biometrics to measure the impact of 
secondary brain maturation and growth following 
preterm brain injury.52–54 These neonatal MRI scoring 
systems underwent further development to include 
evaluation of deep grey matter structures and the 
cerebellum20 and this version will be used in this study 
for infants who underwent neonatal MRI.
2. Prechtl’s General Movements Assessment (GMs): The 
GMs is a diagnostic tool for neurological evaluation 
of at-risk infants.55 56 It has high predictive value for 
neurodevelopmental outcome at 12–24 months (eg, 
sensitivity ≥92% and specificity ≥82%, p<0.01). Infants 
will be video recorded for 5 min at 12–14 weeks ca (fid-
gety period) to determine ‘absent fidgety’ GMs as one 
of the inclusion criteria to the study. Videos will be re-
corded globally for 5 min, then 1 min to focus on each 
hand to detect hemiplegia.57 The GMs will also be rat-
ed by a second masked assessor to confirm ‘Absent 
Fidgety’ or ‘Asymmetric Absent Fidgety’ as markers of 
high risk of CP and high risk of UCP.
3. HAI:This is a criterion, norm referenced assessment, 
which evaluates quality and frequency of hand abil-
ities from 3 to 12 months post-term. Test items were 
developed from a review of the literature, expert 
panel and systematic observations of infants. A Rasch 
measurement model was used to determine internal 
scale validity. The test items assess unilateral and bi-
manual actions, based on the frequency of occurrence 
and quality of performance. The HAI comprises 17 
items, which describe object-oriented hand actions 
scored on a three-point scale. For 12 items, each hand 
is scored separately, which enables quantification of 
asymmetry between limbs. A further five items eval-
uate bimanual hand performance. Scores from each 
section are summed to provide a Both Hands sum 
score, which is converted to an interval level (0–100) 
Both Hands Measure. The HAI will be performed at 
baseline, 6 and 12 months ca.58 Videos of the 6 and 
12-month assessments will be assessed independently 
by a certified rater.59
4. Demographic questionnaire: The demographic 
questionnaire has been developed specifically for 
the study to assess family factors and demographic 
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variables such as socioeconomic status, parental 
education and child factors such as birth history and 
other comorbidities. A measure of social advantage/
disadvantage will also be derived from postcode of 
residence using the Index of Relative Socio-economic 
Advantage/Disadvantage (2006) from the Australian 
Bureau of Statistics (129 Reference). Deciles will be 
reported on a continuum with lower scores reflecting 
greater socioeconomic disadvantage and higher 
scores reflecting socioeconomic advantage.
Classification of the sample at 12 and 24 months ca
All participants will be classified using the:
a. Manual Abilities Classification System for Infants 
(mini-MACS): The mini-MACS will be used to classify 
the infants’ ability to handle objects in daily activities 
on one of five levels.60 The mini-MACs version of the 
MACs for children aged less than 4 years will be used 
in this study and this has strong content validity and 
inter-rater reliability in both parents and therapists 
for infants aged 12–51 months61. The Intraclass 
Correlation Coefficient between parents and 
therapists on the mini-MACs was 0.90 (95% CI 0.79 
to 0.92) and for the two therapists was 0.97 (95% 
CI 0.78 to 0.92). Children will be classified on mini-
MACs by an occupational therapist on this measure 
in discussion with the caregiver.
b. Gross Motor Function Classification System 
extended and revised version (GMFCS-ER): 
Classifies self-initiated movements related to sitting/
walking over five levels.62 It is based on self-initiated 
movements, antigravity postures and motor skills 
expected in a typical 5-year old. Children who are 
independently ambulant are classified as GMFCS I 
or II, those requiring an assistive mobility device to 
walk classified as GMFCS III and those in wheeled 
mobility as GMFCS IV and V. Most children in 
the REACH study will be GMFCS level I or II. The 
GMFCS has internationally established validity, 
reliability and stability for the classification and 
prediction of motor function of children with 
CP aged 2–12 years63.64 It has a high inter-rater 
reliability (generalisability coefficient=0.93).64 In 
the current study, the <2 years descriptions are used. 
Lower inter-rater reliability is documented for the 
<2 years age band (κ=0.55), as younger children’s 
gross motor abilities are more variable, and less 
developmental information is available on which 
to base the classification.65 The intrarater (test–
retest) reliability from <2 to 12 years appeared to be 
acceptable (generalisability coefficient=0.68). The 
GMFCS has been correlated with a number of motor 
scales, as well as CP distribution and type of motor 
impairment.65
c. Motor Type and Distribution: Motor type of CP will 
be classified by a medical practitioner as spastic, 
dystonic, ataxic, hypotonic, choreoathetosis, mixed 
CP or unclassifiable according to Surveillance of 
Cerebral Palsy in Europe guidelines.66 Distribution 
will classified by number of limbs impaired.
d. Classification of the brain lesion at 24 months: 
The nature of the brain lesion will be classified 
from MRIs at 24 months ca using two scales: (a) 
a qualitative (Krageloh Mann)19 and (b) semi-
quantitative classification of brain lesion severity 
using structural MRI (sMRI, Fiori scale).67 The 
American Academy of Neurology68 has concluded 
that a clinical brain MRI should be part of the 
diagnosis of CP, so that all MRIs will be conducted 
as part of clinical best practice. Structural MRI 
will be obtained using a 3T scanner at one of the 
four sites, with at least T1-weighted high-resolution 
magnetisation prepared three-dimensional image, 
T2-weighted spin-echo image and fluid-attenuation-
inversion-recovery (FLAIR) sequences. Structural 
MRI will be evaluated by a paediatric neurologist 
(SF) masked to clinical features and history, for type 
of lesion and to describe a presumed pathogenic 
pattern (eg, stroke, hypoxia/anoxia, toxic, metabolic 
or infective). The brain lesion severity will be 
determined by using a semiquantitative scale (Fiori 
scale) that has demonstrated high inter-rater and 
intrarater reliability67 and strong construct validity 
based on dMRI and functional severity in children 
with unilateral CP.69 In the Fiori scoring system, 
raw scores for lobes, subcortical structures (basal 
ganglia, thalami and brainstem), corpus callosum 
and cerebellum are systematically calculated, where 
higher scores represent more severe pathology. 
Each hemispheric score (HS) is the sum of the lobar 
scores (maximum score of 12). The basal ganglia 
and brainstem score (BGBS) is the sum of left and 
right subcortical structures (basal ganglia, thalamus, 
brainstem and posterior limb of the internal 
capsule) (maximum score of 10). The global score 
is the sum of the right and left HS, BGBS, corpus 
callosum and cerebellum scores (maximum of 40). 
A laterality index will be calculated for each scan 
(range 0–1) to determine the lateralisation of the 
lesion, assuming the HS as the lateralised measure. 
A score approximating 0 indicates a more bilateral 
lesion; a score approaching one more unilateral 
involvement.
prIMAry OutCOMEs
The primary outcome measure at 12 months ca is use 
of the impaired hand as an assisting hand in bimanual 
activities on the Mini-AHA which will be rated blinded to 
group allocation/order from video recordings.
bimanual performance
All infants will be assessed using the Mini-AHA at 
12 months ca and Small Kids AHA at 24 months ca. Both 
of these tests have been developed using Rasch method-
ology and measure the effectiveness with which a child 
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makes use of their impaired hand during bimanual activity 
performance. Test–retest reliability is high for school chil-
dren (ICC 0.98). Small Kids AHA is responsive to change 
following upper limb intervention5 with a smallest detect-
able difference of 3.89 raw scores. The Mini-AHA was 
developed for children 8–18 months and comprises 20 
items rated on a four-point scale. There is evidence for 
internal scale validity and the Mini-AHA distinguishes 
between levels of ability with high precision.70 The test 
developers have demonstrated longitudinal validity of the 
Small Kids AHA and predictive validity of future use of 
the impaired hand as an assisting hand use.71
sECOndAry OutCOMEs
bayley-III72
Infants will be assessed on the Bayley-III (cognitive and 
motor) at 12 months and 24 months ca. Test–retest reli-
ability is 0.67 (fine motor) and 0.83 (gross motor).73
paediatric Evaluation of disability Inventory Computer 
Adapted test (pEdI-CAt)
The PEDI-CAT is a norm referenced, parent-reported 
measure of domains of self-care, mobility and social 
functioning which has good validity and reliability.74 The 
PEDI-CAT is completed online at 12 and 24 months ca 
and will be used to compare outcomes between groups.
EA-sr49
EA-SR is a 32 item self-report measure of emotional avail-
ability with excellent reliability and validity. 
dAss-2148
DASS-21 is a 21-item questionnaire that assesses symptoms 
of depression, anxiety and stress in adults. Respondents 
rate items on a four-point Likert scale reflecting how 
much the statement applied to them in the past week. 
DASS produces three subscales each with good internal 
consistency: the depression (α=0.91), anxiety (α=0.84) 
and stress (α=0.90) scales. DASS also has good discrim-
inant and concurrent validity.48
prIME-G
PRIME-G is a parent report of engagement in the inter-
vention. This measure is part of a suite of measures of 
engagement currently under development (http:// prim-
eresearchteam. com/). PRIME-G is a self-report measure 
comprising 12 items which reflect affective, behavioural 
and cognitive aspects of engagement. Items are scored on 
a seven-point Likert scale. It is anticipated that the more 
highly engaged the family the more likely they will be 
to complete the intervention protocol. PRIME-G will be 
assessed at the first home visit conducted by the research 
occupational therapist, then at the midway point of the 
intervention (3 to 4 months following commencement) 
and at 12 months of age at completion of the intervention.
neurodevelopmental Assessment
Neurodevelopmental assessment of the infants, will be 
undertaken by a medical practitioner (paediatrician, 
rehabilitation specialist or neurologist) at 12 and 24 
months of age to confirm the diagnosis, to classify the 
motor type and distribution using HINE.22–25 HINE is 
the most accurate method for early detection of cere-
bral palsy in infants older than 5 months (corrected for 
prematurity) but less than 2 years old to detect neuro-
logical dysfunction (90% predictive of cerebral palsy). 
An infant with a HINE score lower than 73 (at 6, 9 or 
12 months) is considered to be at high risk of cerebral 
palsy. A HINE score lower than 40 (at 6, 9 or 12 months) 
strongly indicates cerebral palsy.23 24
neuroimaging measures
All participants undertaking MRI will be checked for 3T 
MRI safety including no metal implants or ventriculoperi-
toneal shunts. As participants will be 24 months ca at MRI, 
and unable to lie still in the noisy scanner environment, 
their families will be offered MRI under sedation as part of 
clinical follow-up.68 The American Academy of Neurology 
practice parameter has concluded that brain MRI should 
be part of the diagnosis of CP. This is routinely under-
taken as part of best clinical practice after referral by their 
treating doctor.
Diffusion imaging acquisition and white matter fibre tracking
DMRI scans, suitable for structural connectivity anal-
yses will be acquired on 3T scanners at LCCH, Brisbane, 
Murdoch Children’s Research Institute in Melbourne 
and the Children’s Hospital at Westmead in Sydney and 
the Sir Charles Gardner Hospital in Perth. The research 
sequence will be acquired at the same time as clinical 
scans at 24 months ca during natural sleep or using seda-
tion or under general anaesthesia (determined on a 
case by case basis)68 where (Note: dMRI adds 10 min to 
scan time, total scan time 35 min). There are some risks 
associated having a general anaesthetic to undertake the 
MRI. In ambulant children with CP with no other major 
medical conditions (no uncontrolled seizures) the risk 
associated with general anaesthesia is <1% chance of some 
complication. The referring doctor will discuss this with 
the parents in relation to their child. Where families do 
not wish their child to undergo general anaesthesia for 
MRI at 24 months ca, they will be offered a desensitisation 
programme to familiarise the child to the scanner noises 
so that sleeping scans can be performed. Families who 
do not wish75 for their child to have an MRI at 24 months 
can participate in the study without performing the scan.
Diffusion-weighted images will be acquired along 64 
directions, with full brain coverage. DMRI data will be 
preprocessed to reduce artefacts,76 and the fibre orienta-
tion distribution estimated taking into account crossing 
fibres.75 Tractography will be performed to delineate 
corticospinal and thalamocortical pathways.
Quantitative diffusivity indices fractional anisotropy 
and mean diffusivity, will be calculated for the tracts and 
an asymmetry index calculated. This will be performed 
separately for the left/right-sided hemiplegia, cortical/
subcortical regions and uni/bilateral lesions. Our 
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hypothesis is that the Baby mCIMT group will show 
reduced asymmetry due to enhanced plasticity.
sample size determination
Primary basis for sample size calculation is adequate 
power for H1 comparison between functional effects 
of Baby mCIMT compared with Baby BIM therapy at 
12 months ca. Based on data from a study of 2 to 3-year 
olds,28 we propose a mean difference of 6 AHA logit 
points (100-Logit Scale)71 77 as the minimum difference 
likely to have substantial clinical impact. Data from our 
large RCT comparing mCIMT and BIM in school-aged 
children with hemiplegia yielded SD of 12.8 and 12.6 
in each group.8 Assuming a pooled SD of 12.8 units, a 
sample size of 144 participants (72 per treatment) will 
have 80% power to detect a 6-unit difference on AHA 
between groups (2-sided test at p<0.05). We require 150 
children (75 in each group) to allow for attrition (41% 
recruitment of eligible is required as a minimum, there-
fore feasible).
Statistical analysis
Analyses will follow standard principles for RCTs, with 
interest focussing on comparisons between the interven-
tion groups. Analyses will be undertaken on an inten-
tion-to-treat basis, and statistical significance will be 
set at p<0.05. The primary outcome, mini-AHA scores 
at 12 months ca, will be compared between treatment 
groups using generalised linear models. The main effect 
entered will be treatment group (mCMIT/BIM), and 
stratification variables (age, gender, side) will be entered 
as covariables. The distributional family will be Gaussian 
and the identity link will be used. The secondary anal-
yses will use similar methods to compare outcomes 
between groups at 24 months ca for bimanual coordina-
tion (AHA), cognitive development (domains of Bayley 
Scale of Infant Development III) and self-care domains 
of PEDI-CAT. For dichotomous outcomes, the distribu-
tional family will be binomial and the logit link will be 
used. Where continuous data exhibit skewness not over-
come by transformation, non-parametric methods (for 
example the Mann-Whitney U Test or quantile regres-
sion) will be used. For H3,3 magnitude of central changes 
between groups will be determined using quantitative 
analysis of dMRI statistical parametric maps. Data will be 
compared between groups using generalised estimating 
equations.
Validity of results will be checked using baseline and 
general descriptive information available for all eligible 
families. This includes comparing key characteristics 
of families who completed the study with those who 
enrolled in the study but did not complete and those 
who did not enrol. Multiple imputation techniques will 
be used if to adjust for differential drop-out if appro-
priate. Professor Robert Ware, lead biostatistician, will 
provide expert input for guiding and assisting with 
analysis.
EthICs And dIssEMInAtIOn
This study protocol presents the background and design 
for a randomised comparison trial comparing inten-
sive Baby CIMT training to the same dose of Baby BIM 
for children with congenital hemiplegia. The alter-
nate approaches may impact neuroplasticity positively 
(balanced) or negatively (lateralised) which along with 
the duration of therapeutic responses will guide clini-
cians on choice of the most effective treatments. Our 
team has commenced the first implementation studies 
of intensive upper limb therapy in school-aged children 
with hemiplegia,78 and thus findings of this proposed 
study in young infants are able to be translated rapidly 
into clinical practice.
Full ethical approvals for this study have been obtained 
from the Children’s Health Queensland Hospital and 
Health Service Human Research Ethics Committee 
(HREC/14/QRCH/376: ethical review provided for 20 
sites: Lady Cilento Children's Hospital, Royal Brisbane 
and Women's Hospital, Mater Mothers’ Hospital, Gold 
Coast University Hospital, Sunshine Coast University 
Hospital, Nambour General Hospital, The Children’s 
Hospital at Westmead, Children's Hospital Randwick, 
Westmead Hospital, Royal North Shore Hospital, Liver-
pool Hospital, Nepean Hospital, Royal Prince Alfred 
Hospital, Royal Women’s Hospital, St George Hospital, 
Blacktown Hospital, Campbelltown Hospital, John 
Hunter Children’s Hospital, Royal Children’s Hospital 
and Monash Medical Centre), Medical Ethics Committee 
of The University of Queensland (2015000013), Cere-
bral Palsy Alliance Ethics Committee (2015-01-02) and 
the Princess Margaret Hospital Human Research Ethics 
Committee (2015023EP: ethical review provided for two 
sites: Princess Margaret Hospital for Children and King 
Edward Memorial Hospital for Women).
To our knowledge, this study is the first to investigate and 
compare the effects of two approaches to very early upper 
limb rehabilitation for infants at high risk of congenital 
hemiplegia implemented by parents coached by thera-
pists. Furthermore, we will be evaluating outcomes of the 
Baby CIMT versus Baby BIM training programmes across 
all relevant domains of the International Classification of 
Functioning, Disability and Health using the most valid 
and reliable assessment tools available for use. We antic-
ipate that the results of this study will be disseminated 
through peer-reviewed journals and national and inter-
national academic conferences as well as our established 
clinical and consumer networks.
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